About Gene Expression
Gene expression functions as a key pillar of the molecular biology market as multiple molecular biology techniques have been used extensively to study gene expression and gene quantification. Molecular biology techniques such as polymerase chain reaction (PCR); nucleotide sequencing, including next-generation sequencing (NGS); and microarray analysis are the techniques pivotal for the success of a gene expression study. These advancements have contributed to the overall growth of the molecular biology market.
Technavio’s analysts forecast the global gene expression market to grow at a CAGR of 10.56% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global gene expression market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of instruments and consumables used to analyze gene expression.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Gene Expression Market 2017-2021
Technavio recognizes the following companies as the key players in the global gene expression market: Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Fluidigm, GE Healthcare Dharmacon, Illumina, Interpace Diagnostics, Miltenyi Biotec, New England BioLabs, OriGene Technologies, Oxford Nanopore Technologies, PerkinElmer, Phalanx Biotech Group, Promega, QIAGEN, and Zyagen.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of advanced genome editing techniques and genetic screening programs. A high precision and cost-effective technique, CRISPR-Cas9, is a game-changing form of gene editing and is dispersing throughout biotech laboratories and biotech start-ups globally. It has enormous potential as it can detect mutations at the granular level in the human genome, thus creating highly sophisticated results.”
According to the report, one driver in the market is decreasing cost of DNA sequencing. Since DNA sequencing is an essential step in the gene expression protocol, researchers consider the cost of sequencing as an essential parameter when designing their experiments. In the past, after the completion of the human genome project, sequencing techniques involved several trial and error methods, and thus, the resultant cost of the technique was high, resulting in huge cost burden for researchers. However, this scenario has changed drastically due to advancements in science and molecular biology.
Further, the report states that one challenge in the market is shortage of trained healthcare professionals in genomics. Gene expression techniques are highly technical in nature and care must be taken at each step to facilitate a successful experiment and generate reproducible results. It is doubtful whether healthcare professionals in the global genomics market are competent enough to make sense of the huge amount of genomic data being generated from multiple experiments undertaken globally. Priorities in national healthcare systems, access to genomic technologies, and differences in education and training systems among countries further contribute to the inconsistent understanding of genomic data.
Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, Thermo Fisher Scientific, Fluidigm, GE Healthcare Dharmacon, Illumina, Interpace Diagnostics, Miltenyi Biotec, New England BioLabs, OriGene Technologies, Oxford Nanopore Technologies, PerkinElmer, Phalanx Biotech Group, Promega, QIAGEN, and Zyagen.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook